Insider Shareholders with Direct Ownership of Edgewise Therapeutics, Inc. (EWTX)
This section provides a comprehensive overview of the insiders with direct ownership of Edgewise Therapeutics, Inc. (EWTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Edgewise Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Novo Holdings
> 10% Shareholder |
6,071,703 | 0 | 6,071,703 $206 Million | 2 |
Sep 14, 2022
Added 7.39%
|
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
> 10% Shareholder |
681,812 | 0 | 681,812 $23.2 Million | 1 |
Mar 30, 2021
Added 50.0%
|
|
R Michael Carruthers
Chief Financial Officer |
285,484 | 218,585 | 76,904 $2.61 Million | 11 |
Oct 11, 2024
Added 47.65%
|
| 15,625 | 0 | 15,625 $531,250 | 1 |
Mar 30, 2021
Added 50.0%
|
|
|
Behrad Derakhshan
Chief Business Officer |
62,484 | 55,533 | 15,121 $514,114 | 12 |
Sep 20, 2024
Reduced 73.56%
|
| 20,833 | 14,098 | 14,538 $494,292 | 5 |
Sep 20, 2024
Reduced 33.0%
|
|
|
Kevin Koch
President and CEO |
20,833 | 6,355 | 14,478 $492,252 | 4 |
May 02, 2024
Reduced 17.88%
|
|
Alan J Russell
Chief Scientific Officer |
258,001 | 514,863 | 12,719 $432,446 | 33 |
Sep 20, 2024
Reduced 6.02%
|
| 10,857 | 0 | 10,857 $369,138 | 1 |
Dec 26, 2023
Added 50.0%
|
|
|
John R Moore
General Counsel |
318,798 | 320,732 | 3,252 $110,568 | 52 |
Sep 23, 2024
Reduced 86.55%
|